NASDAQ:DLHC - US23335Q1004 - Common Stock
The current stock price of DLHC is 5.5 USD. In the past month the price decreased by -6.62%. In the past year, price decreased by -50.09%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ADP | AUTOMATIC DATA PROCESSING | 30.8 | 124.73B | ||
PAYX | PAYCHEX INC | 28.28 | 50.73B | ||
PAYC | PAYCOM SOFTWARE INC | 26.43 | 13.16B | ||
DAY | DAYFORCE INC | 30.62 | 11.05B | ||
PCTY | PAYLOCITY HOLDING CORP | 25.43 | 10.06B | ||
KFY | KORN FERRY | 15.6 | 4.00B | ||
RHI | ROBERT HALF INC | 21.68 | 3.86B | ||
TNET | TRINET GROUP INC | 14.53 | 3.35B | ||
FA | FIRST ADVANTAGE CORP | 19.45 | 2.98B | ||
NSP | INSPERITY INC | 24.49 | 2.09B | ||
ALIT | ALIGHT INC - CLASS A | 7.3 | 2.09B | ||
MAN | MANPOWERGROUP INC | 12.58 | 2.06B |
DLH Holdings Corp. engages in the provision of technology enabled business process outsourcing program management solutions and public health research and analytics. The company is headquartered in Atlanta, Georgia and currently employs 2,800 full-time employees. The firm is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The firm's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.
DLH HOLDINGS CORP
3565 Piedmont Road, Ne, Building 3, Suite 700
Atlanta GEORGIA 30305 US
CEO: Zachary C. Parker
Employees: 2800
Phone: 18669521647
The current stock price of DLHC is 5.5 USD.
The exchange symbol of DLH HOLDINGS CORP is DLHC and it is listed on the Nasdaq exchange.
DLHC stock is listed on the Nasdaq exchange.
7 analysts have analysed DLHC and the average price target is 10.2 USD. This implies a price increase of 85.45% is expected in the next year compared to the current price of 5.5. Check the DLH HOLDINGS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DLH HOLDINGS CORP (DLHC) has a market capitalization of 79.14M USD. This makes DLHC a Micro Cap stock.
DLH HOLDINGS CORP (DLHC) currently has 2800 employees.
DLH HOLDINGS CORP (DLHC) has a support level at 5.49 and a resistance level at 5.54. Check the full technical report for a detailed analysis of DLHC support and resistance levels.
The Revenue of DLH HOLDINGS CORP (DLHC) is expected to decline by -13.41% in the next year. Check the estimates tab for more information on the DLHC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DLHC does not pay a dividend.
DLH HOLDINGS CORP (DLHC) will report earnings on 2025-12-02, after the market close.
The PE ratio for DLH HOLDINGS CORP (DLHC) is 17.19. This is based on the reported non-GAAP earnings per share of 0.32 and the current share price of 5.5 USD. Check the full fundamental report for a full analysis of the valuation metrics for DLHC.
The outstanding short interest for DLH HOLDINGS CORP (DLHC) is 0.91% of its float. Check the ownership tab for more information on the DLHC short interest.
ChartMill assigns a technical rating of 2 / 10 to DLHC. When comparing the yearly performance of all stocks, DLHC is a bad performer in the overall market: 90.21% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to DLHC. DLHC has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months DLHC reported a non-GAAP Earnings per Share(EPS) of 0.32. The EPS decreased by -37.25% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.28% | ||
ROA | 1.54% | ||
ROE | 4.03% | ||
Debt/Equity | 1.09 |
7 analysts have analysed DLHC and the average price target is 10.2 USD. This implies a price increase of 85.45% is expected in the next year compared to the current price of 5.5.
For the next year, analysts expect an EPS growth of -66% and a revenue growth -13.41% for DLHC